US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing ...

Shares in many large drugmakers initially fell Wednesday on the president's threat, only to rebound later when he announced a ...

The sodium channel blocker market is expanding due to the increasing prevalence of neuropathic pain and the demand for more selective treatments like ...

Drug company shares, which had sunk on comments by Trump that pharma duties would be coming soon, rallied along with the ...